These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11688280)

  • 1. [Hemocoagulation disorder in patients with destructive pancreatitis: the role in pathogenesis and ways of its correction].
    Zemskov VS; Kriuchyna IeA; Koval's'ka IA
    Klin Khir; 2001 Jul; (7):32-5. PubMed ID: 11688280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correction of hemocoagulation disorders in complicated forms of acute cholecystitis].
    Mishalov VG; Terekhov SN; Zaria IL; Sukhoviĭ MV; Semeniaka VI; Aver'ianov EV; Burnaeva SV
    Klin Khir; 2002 Sep; (8):13-6. PubMed ID: 12378928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cryoplasma-anti-enzyme combination in the treatment of acute pancreatitis].
    Tseĭmakh EA; Maletin SI; Smirnov OI; Tolstokorov IG
    Khirurgiia (Mosk); 2002; (4):22-5. PubMed ID: 12001677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation disorders in traumatic brain injury.
    Alexiou GA; Pahatouridis D; Voulgaris S
    J Neurotrauma; 2011 Apr; 28(4):689. PubMed ID: 21309727
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of lower-molecular weight heparin in the prevention of pancreatic encephalopathy in the patient with severe acute pancreatitis.
    Lu XS; Qiu F; Li YX; Li JQ; Fan QQ; Zhou RG
    Pancreas; 2010 May; 39(4):516-9. PubMed ID: 20104197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis and anticoagulant treatment of autoimmune diseases of the kidneys (review of the literature)].
    Shul'tsev GP; Gilunova NI; Tsalenchuk IaP
    Ter Arkh; 1971 Nov; 43(11):18-23. PubMed ID: 4948318
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathogenesis and treatment of hemocoagulation disorders in an acute necrotic pancreatitis].
    Pereiaslov AA; Chuklin SM; Posivnych MM
    Klin Khir; 2006 Oct; (10):26-9. PubMed ID: 17269403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute thrombotic disorders.
    Kuntz JG; Cheesman JD; Powers RD
    Am J Emerg Med; 2006 Jul; 24(4):460-7. PubMed ID: 16787806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute necrotizing pancreatitis and sudden abdominal mass: An unusual complication.
    Rodríguez de Santiago E; Téllez Villajos L; Peñas García B; Foruny Olcina JR; García García de Paredes A; Ferre Aracil C; Albillos Martínez A
    Gastroenterol Hepatol; 2017 Apr; 40(4):292-293. PubMed ID: 26952581
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of anticoagulation therapy with low molecular weight heparin in acute pancreatitis].
    Jiao HB; Qiao Z; Tan XL; Du JD; Fei Y; Wang DD; Li JY; Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):712-4. PubMed ID: 15585141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications of acute forms pancreatitis].
    Koval's'ka IO
    Klin Khir; 2000 May; (5):60-1. PubMed ID: 11288259
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-factor Xa levels: when should they be used?
    Clem JR
    S D Med; 2006 Jun; 59(6):261-2. PubMed ID: 16821477
    [No Abstract]   [Full Text] [Related]  

  • 14. [The influence of clexane on the fibronectin content in the blood plasma in patients with destructive pancreatitis].
    Zemskov VS; Kriuchina EA; Koval'skaia IA
    Klin Khir; 2001 Mar; (3):15-8. PubMed ID: 11482207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of arterial thrombosis with low molecular weight heparins.
    Chesebro JH
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):26-34. PubMed ID: 9399407
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
    Fiessinger JN
    Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood coagulation system in acute pancreatitis].
    Baryshnikova AD
    Vestn Khir Im I I Grek; 1969 Aug; 103(8):13-5. PubMed ID: 5397106
    [No Abstract]   [Full Text] [Related]  

  • 18. Low molecular weight heparins for arterial thrombosis.
    Nenci GG; Minciotti A
    Vasc Med; 2000; 5(4):251-8. PubMed ID: 11213238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemocoagulation disorders in patients with acute pancreatitis].
    Dronov OI; Koval's'ka IO; Burmich KS; Tsymbaliuk RS; Uvarov VIu; Lubenets' TV
    Lik Sprava; 2010; (7-8):38-44. PubMed ID: 21714285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparins: beyond thrombosis in the management of the cancer patient.
    Kakkar AK
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():13-5. PubMed ID: 14730473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.